Magzter GOLD ile Sınırsız Olun
Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin
Denemek ALTIN - Özgür
Zydus Buys Agenus' Biologics Facilities in US for $125 Million
Mint New Delhi
|June 04, 2025
Zydus Lifesciences announced on Tuesday it is acquiring two biologics contract manufacturing facilities in California from US-based Agenus Inc. for a total consideration of up to $125 million.
Zydus Lifesciences announced on Tuesday it is acquiring two biologics contract manufacturing facilities in California from US-based Agenus Inc. for a total consideration of up to $125 million. The deal includes an upfront payment of $75 million, with the remaining $50 million to be paid over the following three years.
The Ahmedabad-based pharmaceutical firm said the acquisition will establish its presence in the rapidly expanding global biologics contract development and manufacturing organization (CDMO) sector.
Bu hikaye Mint New Delhi dergisinin June 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint New Delhi'den DAHA FAZLA HİKAYE
Mint New Delhi
Market nears peak on dollar tailwind
Stocks jump 1.2%, but futures rollovers signal weak conviction
3 mins
November 27, 2025
Mint New Delhi
Why computers are selling like hot cakes again
Sales of laptops, desktops and tablets had a bad time in India after a pandemic boom.
2 mins
November 27, 2025
Mint New Delhi
Softbank’s 40% fall from peak shows worry on OpenAI bet
Growing unease over frothy artificial intelligence (AI) valuations is weighing on shares of SoftBank Group Corp.
2 mins
November 27, 2025
Mint New Delhi
PepsiCo taps gourmet taste buds with Red Rock Deli’s India debut
Snack and cola maker PepsiCo is finally giving gourmet a chance with the launch of Red Rock Deli chips, priced ₹60 and ₹125 a pack, in a shift from its years-long focus on mass-market Lay's that starts as low as ₹5.
2 mins
November 27, 2025
Mint New Delhi
Fintechs turn fund magnets with cross-border licensing
Funders see growth prospects in central bank's payment aggregator-cross border licensing
3 mins
November 27, 2025
Mint New Delhi
'First-gen founders take bigger investment risks'
India’s markets are minting a new class of first-generation millionaires: entrepreneurs who’ve scaled ideas into Initial public offerings (IPOs) and unlocked unprecedented personal wealth.
2 mins
November 27, 2025
Mint New Delhi
Fundamentum readies four portfolio startups for IPOs
Nandan Nilekani-led venture capital firm Fundamentum is lining up at least four companies in its portfolio for a public listing over the next 12-24 months, co-founder and partner Ashish Kumar said.
2 mins
November 27, 2025
Mint New Delhi
Ukrainians resist pressure from Russia—and Trump
Battered by nearly 4 years of war, Ukrainians don’t want to make big concessions to Moscow
4 mins
November 27, 2025
Mint New Delhi
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint New Delhi
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Listen
Translate
Change font size